Ibipinabant
N/A
Report date: 2025/07/11 20:01:15
NME
Base Information
Drug NameIbipinabant
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb SrlcompanySolvay Pharmaceuticals
Active IndicationsN/A
Inactive Indications